Page last updated: 2024-08-23

pravastatin and Hepatitis C

pravastatin has been researched along with Hepatitis C in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andrus, MR; East, J1
Furusyo, N; Hayashi, J; Maeda, S; Ohnishi, H; Okada, K; Sawayama, Y1
Higashi, MK; Phillips, KA; Veenstra, DL1

Reviews

1 review(s) available for pravastatin and Hepatitis C

ArticleYear
Use of statins in patients with chronic hepatitis C.
    Southern medical journal, 2010, Volume: 103, Issue:10

    Topics: Adult; Cardiovascular Diseases; Contraindications; Hepatitis C; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Liver Function Tests; Pravastatin; Transaminases

2010

Trials

1 trial(s) available for pravastatin and Hepatitis C

ArticleYear
Both hepatitis C virus and Chlamydia pneumoniae infection are related to the progression of carotid atherosclerosis in patients undergoing lipid lowering therapy.
    Fukuoka igaku zasshi = Hukuoka acta medica, 2006, Volume: 97, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Carotid Artery Diseases; Chlamydophila Infections; Chlamydophila pneumoniae; Disease Progression; Female; Hepatitis C; Humans; Male; Middle Aged; Pravastatin; Probucol

2006

Other Studies

2 other study(ies) available for pravastatin and Hepatitis C

ArticleYear
Transplanted livers and kidneys for HIV+ people.
    TreatmentUpdate, 2001,Spring, Volume: 12, Issue:12

    Topics: Antiretroviral Therapy, Highly Active; Cyclosporine; Hepatitis B; Hepatitis C; HIV Infections; Humans; Hypolipidemic Agents; Kidney Transplantation; Liver Failure; Liver Transplantation; Lovastatin; Pravastatin; Renal Insufficiency; San Francisco

2001
Assessing the cost-effectiveness of pharmacogenomics.
    AAPS pharmSci, 2000, Volume: 2, Issue:3

    Topics: Anticholesteremic Agents; Anticoagulants; Antimetabolites, Antineoplastic; Cardiovascular Diseases; Carrier Proteins; Child; Cholesterol Ester Transfer Proteins; Cost-Benefit Analysis; Drug Therapy; Genotype; Glycoproteins; Hepatitis C; Humans; Interferons; Mercaptopurine; Methyltransferases; Pharmacogenetics; Pharmacology, Clinical; Phenotype; Pravastatin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Ribavirin; Warfarin

2000